The board has rejected both of Anne Wojcicki’s buyout proposals to save the struggling genetics company
Seven of eight members of 23andMe’s board have resigned in yet another blow to the struggling genetics company. The CEO is now the only remaining member.
The independent directors of the genetic testing firm said in a letter posted Tuesday that they were quitting the company’s board after not receiving a satisfactory buyout offer from the CEO, Anne Wojcicki.
More Stories
Sweden warns of heightened risk of Russian sabotage
NHS in England to trial AI tool to predict risk of fatal heart disease
Rise of almost untreatable superbug linked to a common antibiotic